cangrelor
SMILES | CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O |
InChIKey | PAEBIVWUMLRPSK-IDTAVKCVSA-N |
Chemical properties
Hydrogen bond acceptors | 15 |
Hydrogen bond donors | 7 |
Rotatable bonds | 15 |
Molecular weight (Da) | 774.9 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Database connections
Ligand site mutations | P2Y12 |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
P2Y12 | P2Y12 | Human | P2Y | A | pIC50 | 8.7 | 8.7 | 8.7 | Guide to Pharmacology |
P2Y13 | P2Y13 | Human | P2Y | A | pIC50 | 8.3 | 8.3 | 8.3 | Guide to Pharmacology |
GPR17 | GPR17 | Mouse | A orphans | A | pIC50 | 8.92 | 8.92 | 8.92 | Guide to Pharmacology |
P2Y12 | P2Y12 | Human | P2Y | A | pIC50 | 7.74 | 9.02 | 9.4 | ChEMBL |
P2Y12 | P2Y12 | Human | P2Y | A | pIC50 | 8.06 | 8.06 | 8.06 | Drug Central |
P2Y13 | P2Y13 | Human | P2Y | A | pIC50 | 8.08 | 8.08 | 8.08 | Drug Central |
GPR17 | GPR17 | Mouse | A orphans | A | pIC50 | 8.05 | 8.05 | 8.05 | Drug Central |
GPR17 | GPR17 | Human | A orphans | A | pIC50 | 9.15 | 9.15 | 9.15 | ChEMBL |